Published in Ann Oncol on February 06, 2006
AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ (2010) 8.73
Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ (2010) 3.80
Improving the use of research evidence in guideline development: introduction. Health Res Policy Syst (2006) 3.31
Evidence-informed health policy 1 - synthesis of findings from a multi-method study of organizations that support the use of research evidence. Implement Sci (2008) 2.15
A systematic scoping review of adherence to reporting guidelines in health care literature. J Multidiscip Healthc (2013) 1.07
Do guidelines influence the implementation of health programs?--Uganda's experience. Implement Sci (2012) 0.91
Heterogeneity in cancer guidelines: should we eradicate or tolerate? Ann Oncol (2008) 0.90
Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study. BMJ (2015) 0.85
A flood tide of systematic reviews on endodontic posts: methodological assessment using of R-AMSTAR. Clin Oral Investig (2013) 0.77
Need for quality improvement in renal systematic reviews. Clin J Am Soc Nephrol (2008) 0.76
Are Guidelines Guiding us on How to Utilize Laboratory Tests? EJIFCC (2015) 0.75
Evidence-based guidelines: Improving AGREEment on consistence evaluation. J Bone Oncol (2012) 0.75
General and abdominal adiposity and risk of death in Europe. N Engl J Med (2008) 14.49
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet (2000) 8.10
Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol (1998) 3.65
Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J Natl Cancer Inst (2000) 3.55
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol (1997) 3.39
Consumer participation in research and health care. BMJ (1997) 3.38
What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol (2000) 3.37
Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet (1996) 3.17
A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol (1986) 3.14
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer (2005) 3.04
Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package. JAMA (1995) 2.62
Randomized clinical trials on medical treatment of glaucoma. Are they appropriate to guide clinical practice? Arch Ophthalmol (1993) 2.44
XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis (2001) 2.35
Socioeconomic inequalities in mortality among women and among men: an international study. Am J Public Health (1999) 2.31
Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis. JAMA (1989) 2.18
Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer (2000) 2.16
Effects of clinical pathways in the joint replacement: a meta-analysis. BMC Med (2009) 2.06
ras Mutations and a cup of coffee: cause, confounder, effect modifier, or what else? J Epidemiol Community Health (1999) 2.04
Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics (1992) 2.02
TbetaR-I(6A) is a candidate tumor susceptibility allele. Cancer Res (1999) 1.99
Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2005) 1.98
Disclosure of breast cancer diagnosis: patient and physician reports. GIVIO (Interdisciplinary Group for Cancer Care Evaluation, Italy) Ann Oncol (1991) 1.87
Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials. Ann Oncol (1997) 1.85
Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. J Natl Cancer Inst (1990) 1.78
Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ (1998) 1.75
A European version of the Appropriateness Evaluation Protocol. Goals and presentation. The BIOMED I Group on Appropriateness of Hospital Use. Int J Technol Assess Health Care (1999) 1.73
[Incidence and age of onset of larynx, bladder and infantile tumours in the Province of Turin in relation to industrial development(author's transl)]. Med Lav (1981) 1.72
Occupational class and ischemic heart disease mortality in the United States and 11 European countries. Am J Public Health (1999) 1.68
The impact of patient management guidelines on the care of breast, colorectal, and ovarian cancer patients in Italy. Med Care (1991) 1.62
Reliability study of the European appropriateness evaluation protocol. Int J Qual Health Care (1999) 1.59
DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis (2005) 1.54
Consumption of vegetables, fruit and other plant foods in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts from 10 European countries. Public Health Nutr (2002) 1.53
Alcohol consumption and risk of Hodgkin's lymphoma and multiple myeloma: a multicentre case-control study. Ann Oncol (2006) 1.52
Incessant ovulation and ovarian cancer: a critical approach. Int J Epidemiol (1983) 1.51
Essential requirements for practice guidelines at national and local levels. Neurol Sci (2004) 1.49
Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco. Proc Natl Acad Sci U S A (1988) 1.49
DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer (2001) 1.48
A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St. Vincent Declaration. Diabet Med (1996) 1.46
The risk of bias from omitted research. BMJ (2000) 1.43
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol (2013) 1.43
Do specialists do it better? The impact of specialization on the processes and outcomes of care for cancer patients. Ann Oncol (1998) 1.43
The consequences of under-use of coronary revascularization; results of a cohort study in Northern Italy. Eur Heart J (2001) 1.41
The contribution of cigarette smoking to bladder cancer in women (pooled European data). Cancer Causes Control (2001) 1.40
Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2008) 1.38
Socio-economic inequalities in mortality. Methodological problems illustrated with three examples from Europe. Rev Epidemiol Sante Publique (1998) 1.37
Plasma carotenoids as biomarkers of intake of fruits and vegetables: individual-level correlations in the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Clin Nutr (2005) 1.36
Mediterranean dietary pattern and cancer risk in the EPIC cohort. Br J Cancer (2011) 1.35
Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer (2006) 1.34
Relevance of metabolic polymorphisms to human carcinogenesis: evaluation of epidemiologic evidence. Pharmacogenetics (1991) 1.33
Occupation and bladder cancer in males: a case-control study. Int J Cancer (1985) 1.33
Individual susceptibility and prevention of occupational diseases: scientific and ethical issues. J Occup Environ Med (1995) 1.28
Promoting consumers' demand for evidence-based medicine. Int J Technol Assess Health Care (1998) 1.24
Occupational, environmental, and life-style factors associated with the risk of hematolymphopoietic malignancies in women. Am J Ind Med (1999) 1.23
Practice guidelines: useful and "participative" method? Survey of Italian physicians by professional setting. Arch Intern Med (2001) 1.22
A cross-sectional analysis of physical activity and obesity indicators in European participants of the EPIC-PANACEA study. Int J Obes (Lond) (2009) 1.18
Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol Biomarkers Prev (1993) 1.17
Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol (2008) 1.16
Diet, metabolic polymorphisms and dna adducts: the EPIC-Italy cross-sectional study. Int J Cancer (2000) 1.16
Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev (2000) 1.13
Prenatal screening for congenital heart disease with four-chamber and outflow-tract views: a multicenter study. Ultrasound Obstet Gynecol (2006) 1.10
Adherence to the mediterranean diet and risk of breast cancer in the European prospective investigation into cancer and nutrition cohort study. Int J Cancer (2012) 1.10
Updating clinical recommendations for breast, colorectal and lung cancer treatments: an opportunity to improve methodology and clinical relevance. Ann Oncol (2010) 1.09
Estimates of the proportion of bladder cancers attributable to occupation. Scand J Work Environ Health (1986) 1.09
Estimates of the proportion of lung cancer attributable to occupational exposure. Carcinogenesis (1988) 1.09
Inter-observer and intra-observer variability of mammogram interpretation: a field study. Eur J Cancer (1992) 1.09
Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia (2011) 1.08
Occupation and lung cancer in two industrialized areas of northern Italy. Int J Cancer (1988) 1.07
NAT2 slow acetylation and bladder cancer risk: a meta-analysis of 22 case-control studies conducted in the general population. Pharmacogenetics (2000) 1.06
Analysis of epidemiological cohort data on smoking effects and lung cancer with a multi-stage cancer model. Carcinogenesis (2006) 1.06
Peripheral blood CD3 and CD4 T-lymphocyte reduction correlates with severity of liver cirrhosis. Int J Clin Lab Res (1995) 1.05
Bladder cancer and smoking in males: types of cigarettes, age at start, effect of stopping and interaction with occupation. Int J Cancer (1984) 1.05
Phenoxy herbicides and soft-tissue sarcomas in female rice weeders. A population-based case-referent study. Scand J Work Environ Health (1987) 1.05
Variety in vegetable and fruit consumption and the risk of gastric and esophageal cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2012) 1.05
Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis. Cochrane Database Syst Rev (2008) 1.04
A multicenter case-control study in Italy on hematolymphopoietic neoplasms and occupation. Epidemiology (2001) 1.04
Social class and cancer survival in Turin, Italy. J Epidemiol Community Health (1997) 1.03
Appropriateness of hospital use: an overview of Italian studies. Int J Qual Health Care (1995) 1.03
Fruits and vegetables consumption and the risk of histological subtypes of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control (2010) 1.02
Oral contraceptives, reproductive history and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2010) 1.01
Medicine, practice and guidelines: the uneasy juncture of science and art. J Clin Epidemiol (1995) 1.01
Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions. Carcinogenesis (2006) 1.01
Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans. Ann Oncol (2012) 1.00
Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort. Allergy (2011) 1.00
Lung cancer in motor exhaust-related occupations. Am J Ind Med (1989) 1.00
Psychological outcomes in women with early breast cancer. BMJ (1990) 0.99
Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens. Eur J Cancer (1993) 0.98
Extrapolation of the evidence on teratogenicity of chemicals between humans and experimental animals: chemicals other than drugs. Teratog Carcinog Mutagen (1985) 0.98
White blood cell DNA adducts and fruit and vegetable consumption in bladder cancer. Carcinogenesis (2000) 0.98
Risk factors for pathologically confirmed benign breast disease. Am J Epidemiol (1984) 0.97
Access to hospital care, clinical stage and survival from colorectal cancer according to socio-economic status. Ann Oncol (2000) 0.96
Social factors, diet and breast cancer in a northern Italian population. Br J Cancer (1984) 0.96
Noncontraceptive estrogen use and the occurrence of ovarian cancer. J Natl Cancer Inst (1982) 0.96
Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Br J Cancer (2012) 0.95
Validation of a method for the estimation of food portion size. Epidemiology (1992) 0.95
Appropriateness of early breast cancer management in relation to patient and hospital characteristics: a population based study in Northern Italy. Breast Cancer Res Treat (2008) 0.93
Evaluation of risk of Parkinson's disease in a cohort of licensed pesticide users. Neurol Sci (2002) 0.93
[A case-control study of melanoma of the skin in the province of Torino, Italy]. Rev Epidemiol Sante Publique (1988) 0.93